Procurement Summary
Country: Brazil
Summary: Acquisition of Oncological Medications. (Process: 25410.007925/2025-47)
Deadline: 17 Jun 2026
Posting Date: 01 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 142423156
Document Ref. No.: 91149/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Object: Electronic Auction - Acquisition of Oncology Medicines. (PROCESS: 25410.007925/2025-47) UASG code: 250052 Notice from: 06/01/2026 from 09:00 to 16:00 Proposal Delivery: from 06/01/2026 at 09:00 CYCLOSPORINE, CONCENTRATION 100 MG Quantity: 5060 CYCLOSPORINE, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM, ORAL SOLUTION Quantity: 50 CISPLATIN, CONCENTRATION 50 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 3998 CITARABINE, HYCLORHYDRATE COMPOSITION, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 3097 DACARBAZINE, CONCENTRATION 200 MG, INJECTABLE USE Quantity: 2967 DECITABINE, CONCENTRATION 50 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 176 DOCETAXEL, CONCENTRATION 20 MG/ML, INJECTABLE PHARMACEUTICAL FORM Quantity: 6494 DOCETAXEL, CONCENTRATION 40 MG/ML, INJECTABLE PHARMACEUTICAL FORM Quantity: 6278 DOXORUBICIN HYCLORHYDRATE, DOSAGE 50 MG, INJECTABLE INDICATION Quantity: 6744 DOXORUBICIN HYCLORHYDRATE, DOSAGE 50 MG, INJECTABLE INDICATION Quantity: 6750 ETOPOSIDE, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 5033 DASATINIB, CONCENTRATION 20 MG Quantity: 7660 DASATINIB, CONCENTRATION 100 MG Quantity: 11270 G1 Quantity:
Documents
Tender Notice